Literature DB >> 8371169

Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume.

D J Cole1, P M Patel, L Reynolds, J C Drummond, S Marcantonio.   

Abstract

Arachidonic acid metabolism results in the generation of oxygen radicals and production of prostanoids which are proposed to adversely influence cerebral ischemia. Inhibition of cyclooxygenase, an enzymatic step in arachidonic acid metabolism, has effected an improvement in histologic outcome after cerebral ischemia. However, there has been no attempt to determine whether this effect occurs during vascular occlusion or during reperfusion. We assessed the effect of cyclooxygenase inhibition on infarct volume in the setting of either temporary or permanent middle cerebral artery occlusion (MCAo). Rats were allotted to one of the following groups: Groups I and II, 180 min of MCAo and 120 min of reperfusion; and Groups III and IV, 180 min of permanent MCAo. In Groups I and III, vehicle only was given, whereas in Groups II and IV, ibuprofen was given throughout the study period (MCAo with or without reperfusion). After the ischemic period the brains were analyzed for infarct volume (mm3, mean +/- S.D.) by 2,3,5-triphenyltetrazolium chloride stain. For animals in which reperfusion was allowed, ibuprofen reduced infarct volume (Group I, 122 +/- 15 mm3 vs. Group II, 63 +/- 7 mm3). However, in animals with permanent MCAo, ibuprofen worsened infarct volume (Group III, 79 +/- 8 mm3 vs. Group IV, 110 +/- 13 mm3). These data suggest that the beneficial effect of cyclooxygenase inhibition occurs during reperfusion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371169

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

Authors:  C Iadecola; K Niwa; S Nogawa; X Zhao; M Nagayama; E Araki; S Morham; M E Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism.

Authors:  M Kapoor; A N Clarkson; B A Sutherland; I Appleton
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Brain damage in preterm newborns and maternal medication: the ELGAN Study.

Authors:  Crystal P Tyler; Nigel Paneth; Elizabeth N Allred; Deborah Hirtz; Karl Kuban; Thomas McElrath; T Michael O'Shea; Cindy Miller; Alan Leviton
Journal:  Am J Obstet Gynecol       Date:  2012-07-07       Impact factor: 8.661

4.  Global impairment and therapeutic restoration of visual plasticity mechanisms after a localized cortical stroke.

Authors:  Franziska Greifzu; Silvio Schmidt; Karl-Friedrich Schmidt; Klaus Kreikemeier; Otto W Witte; Siegrid Löwel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-24       Impact factor: 11.205

5.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

7.  Reduction of ischemia-induced cerebral injury by all-trans-retinoic acid.

Authors:  Byung-Kwan Choi; Ji-Hoon Kim; Jong-Soo Jung; Young-Suk Lee; Myoung-Eun Han; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  Exp Brain Res       Date:  2008-12-02       Impact factor: 1.972

Review 8.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

9.  Ibuprofen for neuroprotection after cerebral ischemia.

Authors:  Yusuke Iwata; Olivier Nicole; David Zurakowski; Toru Okamura; Richard A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2009-10-23       Impact factor: 5.209

10.  Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

Authors:  S Nogawa; F Zhang; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.